Search for: "Bio Energy (Washington), LLC" Results 21 - 28 of 28
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 May 2009, 5:20 pm
Todd Dickinson’s comments at Bio Conference (IAM) The Charles Rivers Ventures connection – CRV stakes in RPX Corp, Thinkfire and Intellectual Ventures (IAM) Obama Administration tackling patent backlog (IP Watchdog) Patent examiners told to issue patents (IP Watchdog) More funding needed for patent granting authority (IP Watchdog) Short note on patentability of product-by-process claims – Newman J’s opinion in 1985 case In re Thorpe: Abbott v Sandoz… [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
4 Apr 2008, 1:00 am
: (creativecommons.org), Neil Netanel’s copyright paradox: (Patry Copyright Blog), Isn’t it ironic: TechCrunch blames the music industry for the dangerous ideas of Lessig and the free culture movement: (IPcentral.com) CFP: First interdisciplinary research workshop on free culture: (creativecommons.org), Of limitations, exceptions and verse (WIPO copyright committee): (KEI) Pharma & Biotech Pharma & Biotech - General StemCellPatents.com… [read post]
6 Nov 2007, 7:43 pm
Department of Energy 3:00-4:00 - Cutting Edge Legal Issues in BiotechnologyRudolf H. [read post]